1Parkin DM. Global cancer statistics in the year of 2000 [J]. Lancet Oncol, 2001, 2(9):543-552
2Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials [J].BMJ, 1995, 311(7010): 899～909
3Crino L, Scagliotti GV, Ricci S, et al. Gemcitabine and cisplatin versus mitomycin, ifosfamice,and cisplatin in advanced non-samll-cell lung cancer: A randomized phase Ⅲ study of the Italian Lung Cancer Project[J].J Clin Oncol, 1999, 17(11): 3522～3530
4Rudd R, Gower NH, James LE, et al. Phase Ⅲ randomized comparison of gemicitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC)[J]. Proc Am Soc Clin Oncol , 2002, 21: 292a (abstr 1164)
5Tan E, Souquet P, PereiraJ, et al. Glob: Final results of a prospective randomized phase Ⅲ trial comparing vinorelbine and cisplatin (NP) versus vinorelbine, ifosfamide, and cisplatin (NIP) in metastatic non small cell lung cancer (NSCLC) patients (pts)[
6Bonomi PD, Finkelstein DM, RuckdeschelJC, et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage Ⅳ non-small-cell lung cancer: A study of the Eastern Cooperative Oncology Group[J]. J Clin Oncol , 1989,7(11): 16
7Waller D, Stephens R J, Spiro SG, et al. The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC)-Preliminary results in the surgical setting [J]. Proc Am Soc Clin Oncol,2003,
8Le Chevalier T for the IALT Investigators. Results of the randomized Intemational Adjuvant Lung Cancer Trial (IALT): Cisplatin-based chemotherapy (CT) vs. no CT in 1867 patients(pts) with resected non-small cell lung cancer (NSCLC) [J]. Proc Am Soc Clin O
9Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer: West Japan Study Group for Lung Cancer Surgery[J]. J Clin Oncol, 1996, 14 (4): 1048-1054
10Wada H, Miyahar R, Tanaka F, et al. Postoperative adjuvant chemotherapy with PVM (cisplatin + vindesine + mitomycin C) and UFT (uracil + tegafur) in resected stage Ⅰ - Ⅱ NSCLC (non-small cell lung cancer): A randomized clinical trial-West Japan Study Gr
6Kennedy B J.Thesnail's pace of lung carcinoma chemotheraphy[J].Cancer,1998,82(5):801-803
7Morikawak,HosokawaM,Hamaddj,etal.Possible participation of tumoricidal macrophage in the therapeutic effect of bieomycinona transplantable rat fibro sarcoma[J].CancerRes,1996,46
8Rixe O,Ortuzar W,Alvarez M,et,al.Oxaliplatin,tetralatin,cisplatin,and carboplatin:spectrum of activity in drug resistant cell lines and in the cell lines of the nation cancer institute's anticancer drug screen panel[J].Biochem Pharmacol,1996,52(12):1855-1858
